RPG Life Sciences informs about investor presentation

In furtherance to letter dated January 27, 2026 pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, RPG Life Sciences has enclosed a revised Investor Presentation with respect to Unaudited Financial Results of the Company for the quarter ended December 31, 2025.

The above information is a part of company’s filings submitted to BSE.